SCHEMBL4763545

SCHEMBL4763545

O=C(O)CC1CCc2cc(Cl)ccc2N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGB3 P05106 2/20 0.40
▸ ITGA2B P08514 2/20 0.40
▸ GRIN2D O15399 1/20 0.39
▸ GRIN3B O60391 1/20 0.39
▸ GRIN1 Q05586 1/20 0.39
▸ GRIN2A Q12879 1/20 0.39
▸ GRIN2B Q13224 1/20 0.39
▸ GRIN2C Q14957 1/20 0.39
▸ GRIN3A Q8TCU5 1/20 0.39
▸ FFAR4 Q5NUL3 1/20 0.39
▸ MTNR1A P48039 2/20 0.39
▸ ESR1 P03372 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ SRD5A1 P18405 3/20 0.38
▸ POLB P06746 1/20 0.37
▸ SRD5A2 P31213 1/20 0.37
▸ ITGB2 P05107 1/20 0.37
▸ ITGB1 P05556 1/20 0.37
▸ ITGAV P06756 1/20 0.37
▸ ITGA5 P08648 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6194447 0.82 TRPM5 (0.43) MTNR1AESR1ESR2SRD5A1AHR
SCHEMBL10841342 0.79 AR (0.43) MTNR1AESR1ESR2SRD5A1SRD5A2
SCHEMBL6196313 0.79 ESR1 (0.39) FFAR4MTNR1AESR1ESR2SRD5A1
SCHEMBL6196312 0.78 GAA (0.45) ESR1ESR2SRD5A1SRD5A2AHR
SCHEMBL27528311 0.78 ITGB3 (0.47) ITGB3ITGA2BITGB2ITGB1ITGAV
Hydrochloric Acid SCHEMBL11045497 0.77 GAA (0.44) ESR1ESR2SRD5A1SRD5A2AHR
SCHEMBL18668619 0.76 DRD2 (0.38) GRIN2BFFAR4MTNR1ASRD5A1RIPK1
SCHEMBL17363948 0.73 NR3C1 (0.42) RIPK1CDC25B
SCHEMBL17363934 0.73 NR3C1 (0.42) RIPK1CDC25B
SCHEMBL17363890 0.73 NR3C1 (0.42) RIPK1CDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1963281-A2 HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals, Inc. (US) 2008-09-03 — — EP disclosed
WO-2007075895-A2 HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-07-05 — — WO disclosed
Send feedback